Page last updated: 2024-10-26

etodolac and Experimental Hepatoma

etodolac has been researched along with Experimental Hepatoma in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research Excerpts

ExcerptRelevanceReference
"Etodolac was administered at a low (2 mg/kg) or high (10 mg/kg) dose three times a week for 16 months starting at the age of 3 months."1.33Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor. ( Cheng, J; Hada, T; Hirasawa, T; Imanishi, H; Inagaki, S; Iwamoto, Y; Liu, W; Nakamura, H; Nishiguchi, S; Shimomura, S; Tsujimura, T; Yamamoto, T, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, W1
Nakamura, H1
Tsujimura, T1
Cheng, J1
Yamamoto, T2
Iwamoto, Y1
Imanishi, H1
Shimomura, S1
Hirasawa, T1
Inagaki, S1
Nishiguchi, S1
Hada, T1

Other Studies

1 other study available for etodolac and Experimental Hepatoma

ArticleYear
Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.
    Cancer science, 2006, Volume: 97, Issue:8

    Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Cyclooxygenase 2 Inhibitors; Dinoprostone; Etodol

2006